Kimberly Parkerson
Company: Stoke Therapeutics
Job title: Senior Medical Director
Seminars:
Live Q&A Session with Your Expert Speakers 12:40 pm
day: Day Two
Developing STK-001: An Oligonucleotide Treatment for Dravet Syndrome, Treatment Beyond Seizure Control 11:40 am
Exploring the clinical trial design and global expansion for STK-001 Assessing the enrolment, dosing strategies and secondary endpoints chosen Evaluating safety and pharmacokinetic data from the SAD portion of the MONARCH studyRead more
day: Day Two